Stevanato Group SpA
Open
SectorGezondheidszorg
17.13 1
Overzicht
Wijziging aandelenprijs
24u
Min
16.9
Max
17.17
Inkomsten | -7.9M 39M |
|---|---|
Verkoop | -70M 274M |
K/W Sectorgemiddelde | 31.288 49.052 |
EPS | 0.13 |
Winstmarge | 14.343 |
Werknemers | 6,010 |
EBITDA | -25M 65M |
Aanbevelingen | Strong Buy |
|---|---|
12 Maanden Prognose | +28.81% upside |
Volgende Winsten | 4 aug 2026 |
|---|
Marktkapitalisatie | 183M 5B |
|---|---|
Vorige openingsprijs | 16.13 |
Vorige sluitingsprijs | 17.13 |
Nieuwssentiment
By Acuity
50%
50%
146 / 342 Rangschikking in Healthcare
Stevanato Group SpA Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.